About NovaPharm
Four connected capabilities. One governed route to market.
Services, regulatory and quality, clinical-development support and technology are organised around the decision a partner needs to make.
01Services
Commercial questions begin with operating evidence.
Product assessment, sourcing, launch readiness and outsourced logistics planning are connected through explicit evidence and authority gates.
Explore services02Regulatory and quality
No commercial release before the applicable permissions.
The roadmap connects authorisation readiness, product status, QMS, GDP, vendor oversight, pharmacovigilance and document integrity.
Review regulatory and quality03Clinical research and CRO
Focused programme coordination with a clear evidence boundary.
NovaPharm can frame development questions and coordinate qualified specialists without presenting itself as a global full-service CRO or trial sponsor.
Review clinical-development support04Technology
Digital controls make evidence easier to govern.
Implemented foundations remain distinct from capabilities in development or planned for a later authorised operating environment.
Explore technologyStart a qualified conversation